Quality

Hotspotting does not reduce readmissions


 

Background: In the United States, 5% of the population use half of the annual spending for health care services and 1% account for approximately a quarter of annual spending, considered “superutilizers” of U.S. health care services. The Camden Coalition of Healthcare Providers (the Coalition) developed a model using hospital admission data to identify superutilizers, termed “hotspotting,” which has gained national recognition. Unlike other similar programs, this model targets a more diverse population with higher utilization than other programs that have been studied.

Dr. Sadie Trammell-Velasquez, UT Health San Antonio

Dr. Sadie Trammell-Velasquez


Study design: Randomized, controlled trial.

Setting: Two hospitals in Camden, N.J., from June 2, 2014, to March 31, 2018.

Synopsis: Eight-hundred superutilizers (at least one hospital admission at any of the four Camden-area hospital systems in the past 6 months, greater than one chronic medical condition, more than one high-risk traits/conditions) were randomly assigned to the intervention group or usual care. Once enrolled in the hospital, a multidisciplinary team began working with the patient in the intervention group on discharge. Team members conducted home visits, scheduled/took patients to appointments, managed medications, monitored and coached patients in disease-specific self-care, and assisted with applying for social and other assistive programs.

The readmission rate within 180 days after hospital discharge (primary outcome) between groups was not significant, with 62.3% readmitted in the intervention group and 61.7% in the control group. There was also no effect on the defined secondary outcomes (number of readmissions, proportion of patients with more than two readmissions, hospital days, charges, payments received, mortality).

The trial was not powered to detect smaller reductions in readmissions or to analyze effects within specific subgroups.

Bottom line: The addition of the Coalition’s program to patients with very high use of health care services did not decrease hospital readmission rate when compared to usual care.

Citation: Finkelstein A et al. Health care hotspotting – a randomized, controlled trial. N Engl J Med. 2020;382:152-62.

Dr. Trammell-Velasquez is a hospitalist and associate professor of medicine at University of Texas Health, San Antonio.

Recommended Reading

CMS launches hospital-at-home program to free up hospital capacity
The Hospitalist
Higher 10-day mortality of lower-acuity patients during times of increased ED crowding
The Hospitalist
In-hospital mobility impairment in older MI patients predicts postdischarge functional decline
The Hospitalist
Survey offers a snapshot of nationwide COVID-19 discharge practices
The Hospitalist
Hospital at Home: Delivering hospital-level care without the hospital
The Hospitalist
Making sense of LAMA discharges
The Hospitalist
Hospital admissions of nursing home patients declined after ACA quality initiatives
The Hospitalist
Hospitalists play key role in advance care planning
The Hospitalist
Hospital-level care at home for acutely ill adults may be as safe as inpatient care
The Hospitalist
Post–acute kidney injury proteinuria predicts subsequent kidney disease progression
The Hospitalist
   Comments ()